
    
      Participants coming on study will be assigned to two groups：Acarbose+Saxagliptin and
      Metformin+Saxagliptin. It may take 1 weeks to be stabilize to a standardized dose, and then
      the investigators will follow-up the patients for 3 months.During the period,patients will be
      asked to come back to the investigators center to receive the related examination every
      month. The investigators will detect HbA1c，fasting and postprandial C-peptide before and
      after the interventions.
    
  